HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 56 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q2 2020 | $9,000 | +200.0% | 11,891 | +0.3% | 0.00% | – |
| Q1 2020 | $3,000 | -57.1% | 11,858 | +10.7% | 0.00% | – |
| Q4 2019 | $7,000 | 0.0% | 10,709 | -0.2% | 0.00% | – |
| Q3 2019 | $7,000 | -58.8% | 10,729 | +2.2% | 0.00% | – |
| Q2 2019 | $17,000 | -34.6% | 10,500 | 0.0% | 0.00% | – |
| Q1 2019 | $26,000 | +333.3% | 10,500 | +320.0% | 0.00% | – |
| Q4 2018 | $6,000 | – | 2,500 | +4066.7% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 60 | -99.6% | 0.00% | – |
| Q2 2018 | $44,000 | +214.3% | 13,539 | +238.5% | 0.00% | – |
| Q1 2018 | $14,000 | – | 4,000 | +57042.9% | 0.00% | – |
| Q4 2017 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 7 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,280,185 | $9,755,000 | 1.01% |
| Cormorant Asset Management, LP | 201,000 | $1,532,000 | 0.24% |
| PUTNAM INVESTMENTS LLC | 575,692 | $4,386,000 | 0.01% |
| Alyeska Investment Group, L.P. | 114,113 | $870,000 | 0.01% |
| VANGUARD GROUP INC | 4,355,424 | $131,473,000 | 0.01% |
| BLACKROCK ADVISORS LLC | 463,200 | $3,530,000 | 0.00% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 26,100 | $199,000,000 | 0.00% |
| Ironwood Financial, llc | 870 | $7,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 24,293 | $185,000 | 0.00% |
| Sonora Investment Management, LLC | 500 | $3,000 | 0.00% |